Publications by authors named "Christopher J Patten"

Claim this Profile
E
Estimated time of arrival and debiasing the time saving bias.
Gabriella Eriksson, Christopher J D Patten, Ola Svenson, Lars Eriksson

Ergonomics· December 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
New technologies for assessing UDP-glucuronosyltransferase (UGT) metabolism in drug discovery and development.
Christopher J Patten

Drug Discov Today Technol· July 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Isoniazid mediates the CYP2B6*6 genotype-dependent interaction between efavirenz and antituberculosis drug therapy through mechanism-based inactivation of CYP2A6.
Michael H Court, Fawziah E Almutairi, David J Greenblatt, Suwagmani Hazarika, Hongyan Sheng, Christopher J Patten

Antimicrob Agents Chemother· July 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Characterization of recombinant human carboxylesterases: fluorescein diacetate as a probe substrate for human carboxylesterase 2.
Jie Wang, Eric T Williams, Joanne Bourgea, Y Nancy Wong, Christopher J Patten

Drug Metab Dispos· August 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
CYP4F enzymes are responsible for the elimination of fingolimod (FTY720), a novel treatment of relapsing multiple sclerosis.
Yi Jin, Markus Zollinger, Hubert Borell, Alfred Zimmerlin, Christopher J Patten

Drug Metab Dispos· February 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Driver experience and cognitive workload in different traffic environments.
Christopher J D Patten, Albert Kircher, Joakim Ostlund, Lena Nilsson, Ola Svenson

Accid Anal Prev· September 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
In vitro inhibition of UDP glucuronosyltransferases by atazanavir and other HIV protease inhibitors and the relationship of this property to in vivo bilirubin glucuronidation.
Donglu Zhang, Theodore J Chando, Donald W Everett, Christopher J Patten, Shangara S Dehal

Drug Metab Dispos· November 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Using mobile telephones: cognitive workload and attention resource allocation.
Christopher J D Patten, Albert Kircher, Joakim Ostlund, Lena Nilsson

Accid Anal Prev· May 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Highly selective inhibition of human CYP3Aa in vitro by azamulin and evidence that inhibition is irreversible.
David M Stresser, Marc I Broudy, Thuy Ho, Catherine E Cargill, Andrew P Blanchard, Christopher J Patten

Drug Metab Dispos· January 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluation of 3'-azido-3'-deoxythymidine, morphine, and codeine as probe substrates for UDP-glucuronosyltransferase 2B7 (UGT2B7) in human liver microsomes: specificity and influence of the UGT2B7*2 polymorphism.
Michael H Court, Soundarajan Krishnaswamy, Qin Hao, Su X Duan, Christopher J Patten

Drug Metab Dispos· September 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Assessing pregnancy risks of azole antifungals using a high throughput aromatase inhibition assay.
Laura Kragie, Stephanie D Turner, Christopher J Patten, Charles L Crespi, David M Stresser

Endocr Res· August 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis